1
CARDIOTONICS AND CORONARY VASODILATORS
NURS 1950: Pharmacology I
2
Objective 1: describe the relationship of calcium to electrical activity of the heart
Resting: Preload: Afterload:
3
Heart dependent upon influx of calcium Ca+ enters channels in the cardiac cell
membrane and go into the cell along with Na
K+ comes out Cardiac cells contract
repolarization
4
Objective 2: describe how the ANS affects the heart rate
5
The ANS is the primary controller of heart rate
Cholinergic (parasympathetic) vagal fibers are close to the SA node
Stimulation with acetylcholine slows the heart rate
6
Sympathetic (adrenergic) nerves also innervate the heart
Stimulation causes norepinephrine to be released.
Increases heart rate, slows refractory period
7
8
Objective 3: describe how cardiac drugs affect cardiac action
9
1. Increase or decrease the force of myocardial action
Positive inotropics Negative inotropics
How cardiac drugs work
10
2. Increase or decrease heart rate by altering SA node impulse conduction
Positive chronotropics Negative chronotropics
11
3. Increase or decrease conduction of AV impulses
Positive dromotropics Negative dromotropics
12
Diuretics to decrease blood volume
Figure 24.1 Pathophysiology of heart failure
14
Objective 4: identify the action of cardiac glycosides
15
Digoxin & relatives
Come from Natural sources Helpful in CHF Have a positive inotropic effect
Cardiac glycosides
16
Increases mechanical efficiency of heart This pumps more blood With increased blood to kidneys, diuresis
occurs, edema reduced Cardiac glycosides also have negative
chronotropic effect, Negative dromotropic effect
17
Action◦ Thought that they cause release of free calcium
within the cardiac muscle cell
◦ Also change the electrical activity of myocardium
18
Decrease velocity of electrical conduction, prolong refractory period in AV conduction system
Increase vagal tone
19
Objective 5: relate how the effects of digitalis are beneficial to the client with CHF
Recall the signs/symptoms of CHF
How do you think cardiac glycosides improve this condition?
20
Objective 6: describe the usefulness of digitalis in the treatment of atrial fibrillation
21
What is atrial fibrillation? What activity of the cardiac glycosides
improve this condition?
22
Chronotropic/dromotropic effects◦ Suppress impulse conduction through the AV node◦ This prevents excessive atrial activity from
reaching ventricles
23
Objective 7: list the generic and brand names of the digitalis preparations
Digitalis preparations similar in pharmacological properties, toxic effects
24
Digoxin (Lanoxin, Lanoxicaps): oral or IV Onset 30-120 minutes oral Peaks 2-6 hrs Duration 2-4 days Eliminated by kidney
◦ Used most often as rapid onset, short duration
Prototype
25
Must take apical pulse 1 minute before administration
Hold if under 60, contact MD Blood levels needed
26
Objective 8: define digitalization
27
Digitalization is the administration of digitalis that is more than the maintenance dose
This raises the blood level quickly to therapeutic range◦ May also be called a loading dose
28
Example◦ Oral dose of digoxin 0.5-0.75 mg◦ 0.25-0.5 mg then given every 6-8 hours until
desired blood level reached◦ Then maintenance dose: 0.125-0.5 mg daily
29
Objective 9: list symptoms of digitalis toxicity
30
Digitalis toxicity:◦GI distress: N/V, anorexia, and/or diarrhea (flu like symptoms)
◦May have excessive salivation and abdominal pain
◦Neurological: restless, irritable, lethargy, drowsiness, and/or confusion
31
May have vision changes, changes in color◦May have halos, amblyopia and diplopia
◦Cardiac effects: development of arrhythmias (bradycardia, primary AV block)
32
Objective 10: identify factors which predispose digitalis toxicity
33
Toxicity predisposition: hypokalemia as cardiac muscles more sensitive to the glycosides
Renal impairment as 60-90% excreted by kidney
IV administration: rapid accumulation can occur
Contraindications
34
Treatment◦ Hold the drug◦ Use digoxin immune fab (Digibind) Antigen-binding fragments combine with digoxin to neutralize its action
Lisinopril Animation
Click here to view an animation on the topic of lisinopril.
Diuretics Prototype drug: furosemide (Lasix) Mechanism of action: to increase urine
flow, reducing blood volume and cardiac workload
Primary use: to reduce edema and pulmonary congestion
Adverse effects: dehydration, electrolyte imbalance, hypotension, ototoxicity
Furosemide Animation
Click here to view an animation on the topic of furosemide.
Cardiac Glycosides Prototype drug: digoxin (Lanoxin) Mechanism of action: to cause more
forceful heartbeat, slower heart rate Primary use: to increase contractility or
strength of myocardial contraction Adverse effects: neutropenia,
dysrhythmias, digitalis toxicity
Beta-Adrenergic Blockers Prototype drug: Metoprolol (Lopressor,
Troprol XL) Mechanism of action: block cardiac
action of sympathetic nervous system to slow heart rate and B/P, reducing workload of heart
Primary use: to reduce symptoms of heart failure and slow progression of disease
Adverse effects: fluid retention, worsening of heart failure, fatigue, hypotension, bradycardia, heart block
Vasodilators Drugs: hydralazine (Apresoline);
(isosorbide dinitrate (Isordil) Mechanism of action: to relax blood
vessels Primary use: to lower blood pressure Used for clients who cannot take ACE
inhibitors Adverse reactions: reflex tachycardia,
orthostatic hypotension
Phosphodiesterase Inhibitors Prototype drug: milrinone (Primacor) Mechanism of action: to block enzyme
phosphodiesterase in cardiac and smooth muscle
Primary use: as short-term therapy for heart failure
Adverse effects: hypokalemia, hypotension, ventricular dysrhythmias
46
Objective 11: describe the nursing responsibilities associated with administering cardiac glycosides preparations
47
Take apical pulse 1 full minute Hold if under 60, over 100 in adults Report any evidence of irregular rhythm Observe for toxicity S/S Monitor K+ if on diuretics Encourage K+ rich foods
48
Teach client to take pulse Teach S/S of toxicity If hypothyroid, sensitive to digitalis Draw blood levels periodically
49
Atherosclerosis narrows heart’s vessels Blood flow impeded Demand exceeds supply = anginal pain
Angina
50
Objective 12: describe the actions of the antianginal drugs
51
Drugs are used to dilate coronary arteries This brings in oxygen and nutrients Supply = demand so no pain
Goals
52
Objective 13: identify the drugs used to treat angina pectoris
53
Nitroglycerin Calcium channel blockers Beta blockers ACE inhibitors
54
Nitroglycerin drugs Works by relaxing arterial and venous
smooth muscle Dilate coronary arteries
55
Liquid nitroglycerin unstable, highly volatile Oral tablets stable, non-explosive Can be given sublingual for rapid,
predictable action Can be transmucosal, aerosol translingual
spray, IV, transdermal
56
Transdermal
57
Ointment: placed on paper with inches marked off
Amount prescribed placed on the paper, taped into place
4-8 hours of action (Nitro-bid, Nitrol)
58
Nitroglycerin patches: worn 12-14 hours “Patch-off” period of 6-12 hours Prevents tolerance (Transderm-Nitro, Nitro-Dur)
59
IV nitroglycerin in early treatment, then another form
60
Long acting forms for prophylaxis◦ Erythrityl tetranitrate (Cardilate)◦ Pentaerythritol tetranitrate (PETN)
61
Objective 14: list the side effects of nitroglycerin
62
Tolerance Headache Postural hypotension Dizziness Weakness Syncope
◦ Don’t use alcohol with nitros
63
Nitrates can increase intraocular and/or intracranial pressure
64
Objective 15: identify the nursing responsibilities associated with administering the nitroglycerin preparations
65
Teach: when angina occurs, take 3 tabs in 15 min; if no pain relief, call 911
Keep nitro in original container, cap tightly closed
Store in cool, dry place Rotate sites of topical applications Monitor BP during therapy
66
Shelf-life is 6 months. If burning/stinging sensation under tongue, drug still potent
Replace 3 months after opening bottle
67
Objective 16: identify the beta-adrenergic blocker used to treat angina
68
69
Examples: propranolol, Atenolol Decrease heart rate, contractility
◦ Results in reduction of myocardial oxygen consumption
◦ Better if used with nitrates Can not use in COPD, CHF, heart block,
bradycardia, DM
70
When used with nitrates, hypotensive episodes more likely to occur
Drugs used◦ Atenolol (Tenormin)--prototype◦ Metoprolol (Lopressor)◦ Nadolol (Corgard)◦ Propranolol (Inderal)
71
Objective 17: identify the calcium channel blockers used to treat angina
72
73
Nifedipine (Adalat, Procardia) Diltiazem HCl (Cardizem, Dilacor SR)--
prototype Verapamil (Calan, Isoptin) Bepridil (Vascor) Nicardipine HCl (Cardene)
Examples: calcium channel blockers
74
These drugs create coronary vasodilation, increased coronary blood flow, lowered blood pressure, increased cardiac output, and relax coronary artery spasms
Nitrates Prototype drug: nitroglycerin (Nitrostat) Mechanism of action: relax both arterial
and venous smooth muscle; dilate coronary arteries◦ Short acting-terminate acute angina episode◦ Long-acting-decrease severity and frequency of
episodes
Nitrates (continued) Primary use: for lowering myocardial
oxygen demand Adverse effects: hypotension, dizziness,
headache, flushing of face, rash
Beta-Adrenergic Blockers Prototype drug: atenolol (Tenormin) Mechanism of action: to reduce the
cardiac workload by slowing heart rate and reducing contractility
Primary use: for prophylaxis of stable angina
Adverse effects: fatigue, insomnia, drowsiness, impotence, bradycardia, confusion
Calcium Channel Blockers Prototype drug: diltiazem (Cardizem) Mechanism of action: to reduce cardiac
workload by relaxing arteriolar smooth muscle; dilate coronary arteries
Primary use: for lowering blood pressure; bring more oxygen into myocardium
Adverse effects: hypotension, bradycardia, heart failure, constipation, headaches, dizziness, edema
84
Objective 18: identify the ACE inhibitors used to treat angina
85
86
The angiotensin-converting enzyme inhibitors decrease myocardial oxygen demands
87
Captopril (Capoten) Lisinopril (Prinivil)--prototype Ramipril (Altace)
Examples: ACE inhibitors
ACE Inhibitors Prototype drug: lisinopril (Prinivil, Zestril) Mechanism of action: to enhance
excretion of sodium and water Primary use: to decrease blood pressure
and reduce blood volume; dilate veins Adverse effects: first-dose hypotension,
cough, hyperkalemia, renal failure
90
Objective 19: nursing care
91
Frequency, nature, precipitants of angina attack
Lifestyle changes made Effectiveness of coronary vasodilators in
relief of pain Monitor VS, esp. BP
Assessment
92
Ineffective tissue perfusion, cardiac function RT angina
Risk for injury RT side effects of coronary vasodilators
Deficient knowledge RT health alteration and medication regimen
Nursing diagnoses
93
Client will◦ Verbalize decrease in attacks◦ Not experience injury due to coronary
vasodilitation◦ Verbalize s/s of drug toxicity and report to MD
Goals
94
What teaching is done for clients taking nitroglycerin?
What teaching is done for clients taking calcium channel blockers, ACE inhibitors, beta blockers?
What will the nurse monitor when clients are on these medications?
Implementation